Back to search results

Comprehensive Connected Cancer Care (C4) Program Evaluation

This study is evaluating a program called C4 (Comprehensive Connected Cancer Care). The C4 program aims to improve how cancer care is coordinated, especially with supportive care like social services, and to improve communication between patients and their healthcare team. It does this through patient navigation, a digital tool to assess needs, and training for healthcare staff. You might be able to join if you are an adult (18 or older) with a new cancer diagnosis or cancer that has come back, and you haven't started treatment yet. You also need to have at least one social need (like help with transportation or food) or be at high risk for these needs (for example, if you are from a racial or ethnic minority group, or have Medicaid/no insurance). The study will measure how the C4 program affects your health-related quality of life over 4 months.

Study design
This is an interventional study, meaning participants will receive the C4 program. It plans to enroll 300 participants.
What's involved
You will have your health-related quality of life measured at the start of the study and again after 4 months.
Compensation
Not stated in the trial record.
Follow-up
Your health-related quality of life will be measured at 4 months after enrollment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06326567

Comprehensive Connected Cancer Care (C4): Intervention Evaluation

Recruiting
NAAges 18+InterventionalHealth services
Timothy Mullett
~300 participants
Updated 2026-06-22 on ClinicalTrials.gov
What's tested:C4 Program

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in Health Related Quality of Life (FACT-G7)
Measured over baseline (enrollment) and 4 months

Conditions

Cancer
Health Care Utilization

Explore related trials

Malignant Neoplasm

Where it's being run

1 sites across 1 states
Kentucky1

Study leadership

  • Timothy Mullett, MD · PRINCIPAL_INVESTIGATOR · University of Kentucky

Who to contact

Yvonne Taul, RN
[email protected]
859-323-2354
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients with newly diagnosed or recurrent cancer who have not initiated treatment of any kind, including surgery, medical management, and/or radiation
Patients with one reported social determinants of health (SDOH) need OR patients at high-risk for SDOH needs based on demographic information (racial \& ethnic minorities, medicaid/uninsured populations).
Willingness to provide informed consent to participate

Exclusion

Not able to understand and communicate in English
Unable and/or unwilling to access the internet on a phone, tablet, or computer

What this trial measures

  • Change in Health Related Quality of Life (FACT-G7)baseline (enrollment) and 4 months

    The FACT-G7 is a 7-item version of the Functional Assessment of Cancer Therapy-General (FACT-G), a patient-reported outcome measure used to assess health-related quality of life in patients undergoing cancer therapy. The survey assesses the impacts of cancer therapy in four domains: physical, social/family, emotional, and functional. Higher scores represent higher quality of life.